Banana, cocoa, and avocado are pulling in gene-editing platforms, cell-culture science, and real M&A — capital that used to go almost exclusively to corn, soy, and wheat.

For years, R&D dollars in agriculture have followed acreage. Corn, soy, wheat, and rice draw the bulk of breeding investment because they cover the most farmland and feed the most supply chains. Bananas, cocoa, and avocados — crops grown on a fraction of that acreage, often in a handful of producing countries — have historically been left to incremental, slow-moving improvement.

That pattern is showing real cracks. Over the past 12 to 18 months, the iGrow News database has recorded a cluster of stories where venture capital, strategic buyers, and major food companies are putting meaningful money behind genetics, cell culture, and supply-chain technology for crops that rarely got this kind of attention. The volume is still small relative to row-crop R&D spending, but the names involved — Mars, Corteva Catalyst, Mission Produce — are not minor players experimenting at the margins.

This edition looks at four distinct patterns in that activity: banana's defensive mobilization against disease, cocoa's three-track innovation push, avocado's emergence as a multi-channel financial asset, and the Gulf's approach of importing exotic-crop capability rather than building it in-house. Each section is built directly from named deals, partnerships, and funding figures in the iGrow News database — not projections of where the category might go.